Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10002892HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS10022331HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS10029333HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS10045058HBVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20005969HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20008720HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20041792HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20022109HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20022108HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TVIS20056982HPVENSG00000179097.7protein_codingHTR1FNoNo3355P30939
TCGA Plot Options
Drug Information
GeneHTR1F
DrugBank IDDB00696
Drug NameErgotamine
Target IDBE0000460
UniProt IDP30939
Regulation Typeagonist
PubMed IDs12525272
CitationsBigal ME, Tepper SJ: Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep. 2003 Feb;7(1):55-62.
GroupsApproved
Direct ClassificationErgotamines, dihydroergotamines, and derivatives
SMILES[H][C@@]12CCCN1C(=O)[C@H](CC1=CC=CC=C1)N1C(=O)[C@](C)(NC(=O)[C@H]3CN(C)[C@]4([H])CC5=CNC6=CC=CC(=C56)C4=C3)O[C@@]21O
Pathways
PharmGKBPA164747651
ChEMBLCHEMBL442